Timber Pharmaceuticals Inc (NYSE American:TMBR)

Delayed Data
As of May 07
 -0.18 / -14.17%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Timber Pharmaceuticals Inc have a median target of 12.00, with a high estimate of 12.00 and a low estimate of 12.00. The median estimate represents a +1,000.92% increase from the last price of 1.09.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Hold stock in Timber Pharmaceuticals Inc. This rating has held steady since January, when it was downgraded from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 42.86%
Growthannually -271.13%


Growthquarterly --
Growthannually -77.96%
Key to the earnings and sales forecast charts.